FDA Investigator Anya Dlockett Evans
Anya Dlockett Evans has conducted inspections on 202 sites in 4 countries as of 13 May 2024. See below for a list of the FDA enforcement documents resulting from those inspections.
Investigator Details
Number of Inspected Sites:
202
Last Inspection Date:
13 May 2024
Investigator Role:
FDA Investigator
Redica ID:
Countries of Inspections:
United States of America,
India,
Canada,
France
FDA Investigators that have inspected at least one site in common with Anya Dlockett Evans:
Abby Lmozeke Baker,
Akbar J Zaidi,
Albert F Peacock, PhD,
Althea A Williams,
Amanda J White,
Andrea A Branche,
Angela Mock,
Angela Shepas,
Annette Melendez,
Arie R Dyk,
Ashley N Williams,
Audrey J Yarbrough,
Barbara G Peoples,
Bhanu M Kannan,
Bing Lin,
Blondell W Johnson,
Bobbi J Miller,
Bonnie L Menzel,
Brenda G Stewart Munoz,
Brian Sanders,
Brook Shea,
Bryce A May,
Carol F Robinson,
Cassandra L Abellard,
Cathleen A Castellaw,
Charles D Brown,
Charles L Larson,
Christopher D Rush,
Christopher J Hurst,
Christopher J Smith,
Christopher K Gibbs,
Connie L Hannon Rabel,
Corrine M Carter,
Cynthia A Harris, MD, RN,
Dana M Lewis,
Daniel S Fam,
Danielle Lyke,
Darla J Christopher,
Debra Lboyd Seale,
Decarlos A Gomez,
Denise Connelly,
Denise L Burosh,
Deniza Karacic,
Dennis R Hudson,
Diana L Ayala,
Diane Hall,
Dr. Jason R Caballero,
Elisa M Fleming,
Elmina E Akwo,
Elmina E Mboh,
Emily S Mcgann,
Enspect User,
Eric S Myskowski,
Erma Zaimova,
Ernest Serna, III,
Everard A Irish,
Fernando C Martinez,
Frans E Mercado,
Gloria A Milster,
Grant L Davis,
Habacuc V Barrera,
Hala L Selby,
Hamed Ghoda,
Hoimay Chan,
Iris C Macinnes,
J Elkins,
James M Kewley,
Janet B Abt,
Janice M Hickok,
Jeffrey R Wooley,
Jennifer A Kemp,
Jennifer D Young,
Jennifer Hua,
Jocelyn C Turner,
Jodi M Gatica,
Joel D Martinez,
Jogy George,
Johann M Fitch,
Judy Ellen Ciaraldi,
Karlton T Watson,
Kathleen B Swat,
Kelly D Sheppard,
Kelly J Pegg,
Kenitra D Hewitt,
Kenneth L Smalls,
Kimberly Lewandowski Walker,
Kip J Hanks,
L Grant,
Latorie S Jones,
Laura E Garcia,
Lauren E Skokan,
Lauren M Lilly, PhD,
Lawrence C Coleman,
Leighton Kn Gai,
Lesley Maep Lutao,
Lillie M Young,
Lisa A Doyle,
Lisa M Puttonen,
Lisa R Jennings,
Lisa R Whitt,
Lloyd D Payne,
Lori A Gioia,
Lorie S Hannappel,
Lourdes R Genera,
Lynnette I Riggio,
Maira P Brading,
Marc A Jackson, Jr,
Marc R Dickens,
Mariana F Baxter,
Mark W Babbitt,
Mary E Baker Brown,
Matthew J Gretkierewicz,
Melissa D Kalik,
Merelynn Rhoten,
Michael I Gorman,
Michelle Paxon,
Monique S Frazier,
Nimmy Mathews,
Patricia M Jacobs,
Patrick D Stone, MS,
Pauline N Logan,
Perla M Castillo,
Philip M Steele, PhD,
Phillip D Waldron,
Rebecca Co Bryan,
Rebecca L Stephany,
Rhonda L Dash,
Richard T Riggie,
Robert M Tillman,
Ronda Rloyd Jones,
Rose Ashley,
Rosia E Nesbitt,
Roy Baby,
Ruth E Medcalf,
Saleem A Akhtar,
Scott B Laufenberg,
Scott R Nichols, PhD,
Scott T Ballard,
Shannon A Lowe,
Sharyn K Miller,
Shusheen A Alexander,
Sunitha K Rajaram, PhD,
Tamera H Hunt,
Tara A Gray,
Terrance L Thomas,
Toby Vern H Hill,
Tracy J Washington,
Travis M Beard,
Tricia S Martinez,
Trina K Vick,
William F Lagud, Jr,
William P Tonkins,
Yaw O Osei,
Young M Yoon,
Zerita White
Anya Dlockett Evans's Documents
Publish Date | Document Type | Title |
---|---|---|
June, 2013 | EIR | Stillmeadow Incorporated - EIR, 2013-06-04 |
April, 2009 | FDA 483 | Abbott Medical - Form 483, 2009-04-06 |
December, 2021 | FDA 483 | Koriand'r Williams, M.D. - Form 483, 2022-01-31 |
December, 2021 | EIR | Koriand'r Williams, M.D. - EIR, 2021-12-22 |
November, 2021 | FDA 483 | John Heymach, M.D - Form 483, 2021-11-05 |
April, 2009 | FDA 483 Response | Abbott Medical - Form 483R, 2009-04-13 |
May, 2018 | FDA 483 | Elkhalili, Abdelnaser MD - Form 483, 2018-05-14 |
June, 2013 | FDA 483 | Stillmeadow Incorporated - Form 483, 2013-06-04 |
April, 2009 | EIR | Abbott Medical - EIR, 2009-04-06 |
August, 2019 | FDA 483 | Stefan W. Kreuzer, MD - Form 483, 2019-08-13 |
Experience Redica Systems’ NEW investigator profiles and dashboards
Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:
- Total inspections conducted
- 483 rate
- OAI rate
- Warning Letter rate
- Inspections by Industry, Scope, and Inspection Reason
- And much more
Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.
Talk to sales to access our investigator profiles
Loading...
Investigator Profiles Are Just the Tip of the Iceberg
Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:
Inspection Intelligence
- Pre-Approval Inspection (PAI) trends
- The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
- Latest 483s: see what the trends are across all FDA Investigators
- CFR Heatmap: Citations aggregated by Subpart by Year
Vendor Intelligence
- Full inspection histories for your vendors down to the specific site level
- All of the functionality mentioned above but isolated to just your vendors
Regulatory Intelligence
- Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
- All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more